Dombivli, India

Rahul Bhalchadrarao Kawthekar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glenmark Life Sciences Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rahul Bhalchadrarao Kawthekar. Retrieved from https://idiyas.com/inventor/rahul-bhalchadrarao-kawthekar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Profile: Rahul Bhalchadrarao Kawthekar

Introduction: Rahul Bhalchadrarao Kawthekar is an accomplished inventor based in Palava Dombivali, India. His pioneering work in the field of pharmaceuticals has led to significant advancements, particularly in the preparation of solriamfetol and its novel salts.

Latest Patents: Rahul holds a patent for a process related to solriamfetol, titled "Process for the preparation of solriamfetol and salt thereof." This innovative patent specifically addresses the preparation of solriamfetol dibenzoyl-D-tartaric acid salt and solriamfetol di-p-toluoyl-D-tartaric acid salt. Additionally, it covers the process for the preparation of solriamfetol hydrochloride, showcasing his contributions to the pharmaceutical industry.

Career Highlights: Currently, Rahul is employed at Glenmark Life Sciences Limited, where he continues to work on groundbreaking projects in the life sciences sector. His dedication and expertise have positioned him as a valuable asset to the company and the industry at large.

Collaborations: In his role, Rahul collaborates with talented professionals including Shekhar Bhaskar Bhirud and Samir Naik, with whom he shares a vision for innovation and excellence in pharmaceutical research and development.

Conclusion: Rahul Bhalchadrarao Kawthekar exemplifies the spirit of innovation through his contributions to the preparation of solriamfetol and related compounds. As he continues to push the boundaries of pharmaceutical development at Glenmark Life Sciences Limited, his work promises to impact the industry positively for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…